Pfizer Pauses To Remedy Quality At Irungattukottai Plant

A more effective approach to quality assurance could result from an operational pause at a Pfizer plant in India, where the company is responding to US FDA inspectional observations of poor data integrity and inadequate investigations that are expected to result in a warning letter.